- GMED +2.75%
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings
Yahoo Finance · 1 day ago
Open | 50.56 |
High | 51.77 |
Low | 50.47 |
Mkt Cap | 6.98B |
P/E (TTM) | 48.27 |
Div & Yield | N/A & N/A |
Prev. Close | 50.27 |
52 Wk. Low | 43.39 |
52 Wk. High | 62.88 |
Related stocks
Company
Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania, United States. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 616.53M | 124.60% ▲ |
Net Income | 15.03M | 70.00% ▼ |
Diluted EPS | 0.60 | 78.80% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $0.57 | - |
Q4 2023 | $0.61 | $0.60 |
Q3 2023 | $0.57 | $0.57 |
S&P 500^GSPC | 5,189.83+9.09 (+0.18%) |
Dow 30^DJI | 38,948.45+96.18 (+0.25%) |
Nasdaq^IXIC | 16,347.74-1.50 (-0.01%) |
106.73-8.36% | |
10.57+2.33% | |
Datadog, Inc.DDOG | 113.96-10.25% |